A carregar...
Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
Background: Sildenafil, a phosphodiestase type 5 inhibitor, was approved in 2005 for the treatment of pulmonary arterial hypertension (PAH) in adults and is commonly used off-label for pediatric patients. Little is known, however, about sildenafil’s side effects in this population. Methods: Single i...
Na minha lista:
| Publicado no: | Front Pediatr |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353247/ https://ncbi.nlm.nih.gov/pubmed/25806361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2015.00012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|